# QTTB (Q32 Bio Inc.) - SEC EDGAR Financial Statements

> Q32 Bio Inc. reported $53.74M in revenue and net income of $32.25M for the fiscal year ended December 31, 2025, with a 34.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/QTTB
- Markdown: https://convexityos.com/fundamentals/QTTB.md
- SEC CIK: 0001661998
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:41 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001661998&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $53.74M | Dec 31, 2025 |
| Operating Income | FY 2025 | $18.38M | 34.2% margin |
| Net Income | FY 2025 | $32.25M | 60.0% net margin |
| Diluted EPS | FY 2025 | $0.95 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$33.54M | -62.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $289.6M | Total debt: $5.12M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $53.74M | $0 | -$6.65M | $3.21M | $33.97M | $2.70M | $1.67M | $3.68M | -- |
| Research & Development | $19.16M | $48.14M | $31.73M | $98.35M | $93.08M | $100.4M | $89.40M | $47.95M | $21.38M |
| Total Operating Expenses | $36.84M | $66.10M | $41.60M | $136.5M | $129.9M | $133.0M | $111.6M | $65.25M | $29.66M |
| **Operating Income** | $16.90M | -$66.10M | -$48.26M | -$133.3M | -$95.95M | -$130.3M | -$109.9M | -$59.93M | -$29.66M |
| **EBITDA** | $17.29M | -$65.61M | -$47.76M | -$132.0M | -$87.60M | -$122.3M | -$103.6M | -$58.64M | -$28.97M |
| Interest Expense | -- | -- | $1.50M | -- | -- | -- | -- | -- | -- |
| Income Before Tax | $29.82M | -$46.09M | -$87.08M | $1.20M | -$95.76M | -- | -- | -- | -- |
| Income Tax Expense | $0 | $21K | $318K | $715K | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | $29.82M | -$47.73M | -$53.74M | -$5.00M | -$95.76M | -$128.7M | -$103.9M | -$55.58M | -$29.99M |
| Basic EPS | $2.42 | -$5.12 | -$153.96 | -$0.09 | -$1.73 | -$2.80 | -$2.47 | -$1.95 | -$12.10 |
| **Diluted EPS** | $2.42 | -$6.58 | -$153.96 | -$0.09 | -$1.73 | -$2.80 | -$2.47 | -$1.95 | -$12.10 |
| Basic Shares Outstanding | 12.3M | 9.3M | 349.1K | 57.4M | 55.3M | 45.9M | 42.1M | 28.6M | 2.5M |
| Diluted Shares Outstanding | 12.3M | 9.7M | 349.1K | 57.4M | 55.3M | 45.9M | 42.1M | 28.6M | 2.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | $0 |
| Research & Development | $5.15M | $4.26M | $3.22M | $3.31M | $3.56M | $5.16M | $7.12M | $10.54M |
| Total Operating Expenses | $10.66M | $9.12M | $7.72M | $7.86M | $7.58M | $9.17M | $12.23M | $14.53M |
| **Operating Income** | -$10.66M | -$9.12M | -$7.72M | $45.88M | -$7.58M | -$9.17M | -$12.23M | -$14.53M |
| **EBITDA** | -$10.56M | -$9.02M | -$7.63M | $45.97M | -$7.48M | -$9.07M | -$12.11M | -$14.41M |
| Income Before Tax | -- | -- | -- | $57.73M | -$7.39M | -$9.49M | -$11.03M | -$14.17M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $21K |
| **Net Income** | -$8.92M | -$8.95M | -$7.61M | $57.73M | -$7.39M | -$9.49M | -$11.03M | -$14.19M |
| Basic EPS | -$0.26 | -$0.44 | -$0.54 | -- | -$0.60 | -$0.78 | -$0.90 | -- |
| **Diluted EPS** | -$0.26 | -$0.44 | -$0.54 | -- | -$0.60 | -$0.78 | -$0.90 | -- |
| Basic Shares Outstanding | 34.0M | 20.3M | 14.1M | -- | 12.2M | 12.2M | 12.2M | -- |
| Diluted Shares Outstanding | 34.0M | 20.3M | 14.1M | -- | 12.2M | 12.2M | 12.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $48.30M | $77.97M | $25.62M | $33.99M | $108.4M | $217.4M | $53.77M | $38.22M | $51.58M |
| Short-Term Investments | -- | $0 | $0 | $141.0M | $47.49M | $0 | $208.6M | $176.5M | $78.08M |
| **Cash & Short-Term Investments** | $48.30M | $77.97M | $25.62M | $175.0M | $155.9M | $217.4M | $262.4M | $214.7M | $129.7M |
| Other Current Assets | $20K | $396K | $83K | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $55.05M | $81.88M | $28.72M | $181.0M | $191.9M | $219.6M | $266.6M | $221.7M | $131.6M |
| Property, Plant & Equipment, Net | $979K | $1.37M | $1.78M | $1.08M | $2.25M | $37.00M | $42.72M | $35.64M | $3.15M |
| Other Non-Current Assets | $0 | $116K | $4.61M | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $6.73M | $10.46M | $18.34M | $47.45M | $19.81M | $44.17M | $43.99M | $37.41M | $5.93M |
| **Total Assets** | $61.78M | $92.33M | $47.06M | $228.5M | $211.7M | $263.7M | $310.6M | $259.1M | $137.5M |
| Accounts Payable | $879K | $2.99M | $3.47M | $1.14M | $2.37M | $4.72M | $2.61M | $15.73M | $2.54M |
| Deferred Revenue (Current) | -- | -- | $0 | $1.16M | $3.21M | $5.63M | $809K | $770K | $3.34M |
| **Total Current Liabilities** | $11.35M | $16.46M | $14.11M | $22.58M | $17.23M | $22.66M | $12.37M | $22.52M | $8.86M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $1.16M | $32.14M | $30.14M | $30.75M | $30.07M |
| Other Non-Current Liabilities | $0 | $55.00M | $55.00M | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $8.42M | $70.19M | $104.4M | $27.92M | $24.84M | $45.08M | $39.69M | $40.22M | $30.36M |
| **Total Liabilities** | $19.76M | $86.66M | $118.5M | $50.49M | $42.07M | $67.74M | $52.06M | $62.74M | $39.22M |
| **Total Debt (incl. Leases)** | $5.64M | $6.25M | $6.79M | $29.48M | $23.93M | $15.44M | -- | -- | -- |
| Common Stock | $2.0K | $2.0K | $1.0K | $6.0K | $6.0K | $5.0K | $4.0K | $3.0K | $264 |
| Retained Earnings | -$205.0M | -$234.8M | -$187.1M | -$429.1M | -$424.1M | -$328.4M | -$199.7M | -$95.76M | -$40.18M |
| Accumulated Other Comp. Income | -- | $0 | $0 | -$404K | -$7.0K | $0 | $183K | -$77K | -$73K |
| **Total Stockholders' Equity** | $42.01M | $5.67M | -$182.9M | -$130.7M | $169.7M | $196.0M | $258.5M | $196.4M | -$39.45M |
| Total Equity | $42.01M | $5.67M | -$182.9M | -$130.7M | $169.7M | $196.0M | $258.5M | $196.4M | -$39.45M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $289.6M | $106.3M | $50.75M | $48.30M | $49.04M | $54.83M | $65.48M | $77.97M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Cash & Short-Term Investments** | $289.6M | $106.3M | $50.75M | $48.30M | $49.04M | $54.83M | $65.48M | $77.97M |
| Other Current Assets | $19K | $19K | $20K | $20K | $24K | $77K | $93K | $396K |
| **Total Current Assets** | $291.1M | $109.6M | $57.20M | $55.05M | $50.81M | $58.32M | $68.63M | $81.88M |
| Property, Plant & Equipment, Net | $827K | $804K | $889K | $979K | $1.07M | $1.16M | $1.25M | $1.37M |
| Other Non-Current Assets | -- | -- | -- | $0 | $0 | $570K | $444K | $116K |
| **Total Non-Current Assets** | $6.08M | $6.22M | $6.47M | $6.73M | $6.97M | $7.79M | $10.44M | $10.46M |
| **Total Assets** | $297.2M | $115.9M | $63.67M | $61.78M | $57.78M | $66.12M | $79.07M | $92.33M |
| Accounts Payable | $1.11M | $1.56M | $653K | $879K | $973K | $910K | $2.71M | $2.99M |
| **Total Current Liabilities** | $5.17M | $5.40M | $10.67M | $11.35M | $11.11M | $11.53M | $14.58M | $16.46M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $55.00M | $55.00M | $55.00M | $55.00M |
| **Total Non-Current Liabilities** | $4.36M | $4.56M | $6.69M | $8.42M | $65.12M | $66.82M | $68.51M | $70.19M |
| **Total Liabilities** | $9.53M | $9.96M | $17.36M | $19.76M | $76.23M | $78.35M | $83.08M | $86.66M |
| **Total Debt (incl. Leases)** | $5.12M | $5.30M | $5.47M | $5.64M | $5.79M | $5.95M | $6.10M | $6.25M |
| Common Stock | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$230.5M | -$221.5M | -$212.6M | -$205.0M | -$262.7M | -$255.3M | -$245.8M | -$234.8M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| **Total Stockholders' Equity** | $287.7M | $105.9M | $46.31M | $42.01M | -$18.45M | -$12.23M | -$4.01M | $5.67M |
| Total Equity | $287.7M | $105.9M | $46.31M | $42.01M | -$18.45M | -$12.23M | -$4.01M | $5.67M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $29.82M | -$47.73M | -$113.0M | -$5.00M | -$95.76M | -$128.7M | -$103.9M | -$55.58M | -$29.99M |
| Depreciation & Amortization | $391K | $487K | $499K | $1.29M | $8.35M | $7.96M | $6.32M | $1.29M | $684K |
| Stock-Based Compensation | $5.25M | $4.39M | $1.43M | $13.05M | $17.25M | $13.25M | $7.63M | $2.62M | $277K |
| Change in Payables | -$2.11M | -$1.04M | $2.03M | -$981K | -$2.49M | $2.46M | -$4.45M | $4.38M | $1.72M |
| **Operating Cash Flow** | -$33.54M | -$67.72M | -$18.68M | -$113.7M | -$109.8M | -$94.33M | -$91.36M | -$42.56M | $6.48M |
| Capital Expenditure | $0 | -$75K | -$5.0K | -$1.28M | -$2.40M | -$3.73M | -$21.83M | -$24.94M | -$1.96M |
| **Free Cash Flow** | -$33.54M | -$67.79M | -$18.68M | -$114.9M | -$112.1M | -$98.06M | -$113.2M | -$67.50M | $4.52M |
| Purchases of Investments | -- | -- | -$73.24M | -$157.5M | -$97.39M | -$19.99M | -$286.4M | -$245.3M | -$78.07M |
| **Investing Cash Flow** | $7.00M | $19.93M | -$5.0K | $36.72M | -$50.79M | $204.9M | -$51.80M | -$121.8M | -$81.53M |
| Common Stock Issued | $0 | $42.00M | $0 | $0 | $49.74M | -- | $134.5M | -- | -- |
| **Financing Cash Flow** | -$3.12M | $95.14M | $406K | $596K | $52.17M | $53.09M | $158.2M | $151.0M | $115.2M |
| **Net Change in Cash** | -$29.67M | $47.35M | $5.28M | -$76.35M | -$108.4M | $163.7M | $15.06M | -$13.36M | $40.18M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.92M | -$8.95M | -$7.61M | $57.73M | -$7.39M | -$9.49M | -$11.03M | -$14.19M |
| Depreciation & Amortization | $100K | $100K | $90K | $90K | $100K | $100K | $119K | $120K |
| Stock-Based Compensation | $2.90M | $1.69M | $1.55M | $1.47M | $1.18M | $1.27M | $1.34M | $1.25M |
| Change in Payables | -$476K | $912K | -$226K | -$94K | $63K | -$1.80M | -$277K | $1.73M |
| **Operating Cash Flow** | -$4.42M | -$3.08M | -$6.34M | -$6.18M | -$4.23M | -$10.65M | -$12.48M | -$11.43M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -$2.0K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$11.43M |
| **Investing Cash Flow** | -$52K | $0 | $0 | $7.00M | $0 | $0 | $0 | -$2.0K |
| Common Stock Issued | $0 | $0 | $10.36M | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $187.8M | $58.59M | $8.80M | -- | -- | -- | -- | $317K |
| **Net Change in Cash** | $183.3M | $55.52M | $2.45M | -$742K | -$5.79M | -$10.65M | -$12.48M | -$11.11M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 31.5% | -- | -- | -4154.6% | -282.4% | -4821.0% | -6599.2% | -1626.7% | -- |
| **Net Profit Margin** | 55.5% | -- | -- | -156.0% | -281.9% | -4762.9% | -6237.5% | -1508.6% | -- |
| Return on Equity (ROE) | 71.0% | -841.1% | -- | -- | -56.4% | -65.7% | -40.2% | -28.3% | -- |
| Return on Assets (ROA) | 48.3% | -51.7% | -114.2% | -2.2% | -45.2% | -48.8% | -33.5% | -21.5% | -21.8% |
| Current Ratio | 4.85x | 4.97x | 2.04x | 8.02x | 11.14x | 9.69x | 21.54x | 9.84x | 14.85x |
| Quick Ratio | 4.26x | 4.74x | 1.82x | 7.75x | 9.05x | 9.60x | 21.20x | 9.54x | 14.63x |
| Debt to Equity | 0.13x | 1.10x | -- | -- | 0.14x | 0.08x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -307.3% | -90.6% | +1157.3% | +62.2% | -54.8% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -756.9% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -1593.1% | -- |
| 5Y Revenue / Share Growth | +7323.0% | -100.0% | -14867.3% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 11.2% | 31.9% | 71.8% | 71.0% | -- | -- | -- | -841.1% |
| Return on Assets (ROA) | 10.9% | 29.2% | 52.2% | 48.3% | -72.9% | -79.1% | -75.6% | -51.7% |
| Current Ratio | 56.34x | 20.30x | 5.36x | 4.85x | 4.57x | 5.06x | 4.71x | 4.97x |
| Quick Ratio | 56.05x | 19.68x | 4.76x | 4.26x | 4.41x | 4.75x | 4.49x | 4.74x |
| Debt to Equity | 0.02x | 0.05x | 0.12x | 0.13x | -- | -- | -- | 1.10x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -1172.0% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -187.4% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
